Connor, Clark & Lunn Investment Management (CC&L)
SNY icon

Connor, Clark & Lunn Investment Management (CC&L)’s Sanofi SNY Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.3M Sell
1,835,859
-387,442
-17% -$17.3M 0.15% 130
2026
Q1 		$107M Buy
2,223,301
+1,199,675
+117% +$55.9M 0.25% 89
2025
Q4 		$49.6M Buy
+1,023,626
New +$50.7M 0.13% 145
2024
Q4 		– Sell
-151,445
Closed -$8.73M – 1622
2024
Q3 		$8.73M Buy
+151,445
New +$8.18M 0.04% 314
2024
Q1 		– Sell
-43,622
Closed -$2.17M – 1694
2023
Q4 		$2.17M Buy
43,622
+8,941
+26% +$437K 0.01% 644
2023
Q3 		$1.86M Buy
+34,681
New +$1.85M 0.01% 639
2022
Q4 		– Sell
-382,909
Closed -$14.6M – 1412
2022
Q3 		$14.6M Sell
382,909
-298,696
-44% -$13.3M 0.1% 159
2022
Q2 		$34.1M Buy
681,605
+200,538
+42% +$10.6M 0.21% 81
2022
Q1 		$24.7M Buy
481,067
+362,640
+306% +$18.7M 0.12% 135
2021
Q4 		$5.93M Sell
118,427
-22,603
-16% -$1.12M 0.03% 308
2021
Q3 		$6.8M Buy
141,030
+96,491
+217% +$4.91M 0.04% 297
2021
Q2 		$2.35M Buy
44,539
+2,983
+7% +$156K 0.01% 503
2021
Q1 		$2.06M Buy
41,556
+8,144
+24% +$391K 0.01% 555
2020
Q4 		$1.62M Buy
33,412
+18,251
+120% +$900K 0.01% 555
2020
Q3 		$761K Buy
+15,161
New +$781K 0.01% 674
2018
Q2 		– Sell
-70,677
Closed -$2.83M – 1096
2018
Q1 		$2.83M Sell
70,677
-78,900
-53% -$3.28M 0.02% 347
2017
Q4 		$6.43M Buy
149,577
+48,500
+48% +$2.24M 0.04% 259
2017
Q3 		$5.03M Sell
101,077
-85,700
-46% -$4.15M 0.03% 294
2017
Q2 		$8.95M Buy
186,777
+33,000
+21% +$1.58M 0.06% 196
2017
Q1 		$6.96M Buy
153,777
+129,777
+541% +$5.51M 0.05% 215
2016
Q4 		$971K Buy
+24,000
New +$946K 0.01% 490
2013
Q4 		– Sell
-20,748
Closed -$1.08M – 755
2013
Q3 		$1.08M Buy
+20,748
New +$1.06M 0.01% 259

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SNY Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Sanofi (SNY) stake by 17% in Q2 2026, selling an estimated $17.3M and leaving 1,835,859 shares worth $78.3M. The position accounts for 0.15% of the portfolio, ranked #130.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SNY in Q3 2013 and has held it in 22 quarters since. The position peaked at $107M in Q1 2026. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 1,835,859 shares of Sanofi worth $78.3M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 387,442 Sanofi shares in Q2 2026, an estimated $17.3M.
  • Sanofi made up 0.15% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #130 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Sanofi in Q3 2013 and has held it in 22 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Sanofi position peaked at $107M in Q1 2026.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.